Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation

被引:0
作者
Cillo, Lorenzo [1 ]
Dalla Palma, Anna Benedetta [2 ]
Ricci, Stefania [2 ]
Pedrazzoni, Mario [1 ]
Scita, Matteo [2 ]
Bernardi, Matia [2 ]
Sammarelli, Gabriella [2 ]
Pelagatti, Laura [2 ]
Giuliani, Nicola [1 ,2 ]
机构
[1] Univ Parma, Dept Med & Surg, Viale Antonio Gramsci 14, I-43126 Parma, Italy
[2] Univ Hosp Parma, Hematol & BMT Unit, Dept Onco Hematol, Parma, Italy
来源
EJHAEM | 2024年 / 5卷 / 04期
关键词
autologous stem cell transplantation; early relapse; high risk; multiple myeloma; RANDOMIZED-TRIAL; POOR SURVIVAL; AUTO-SCT; OUTCOMES; IMPACT; ERA;
D O I
10.1002/jha2.924
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A portion of multiple myeloma (MM) patients relapse early or do not respond to first line treatment. Identification of possible clinical and or biological features of these patients remains an unmet medical need. In this study we assesed the predictive markers for early relapse MM, defined as a progressive disease that occurred within 18 months, from autologoust stem cell transplantation (ASCT) in MM patients who did not have primary refractory disease. 74 consecutive MM patients were included in the study that received intensive therapy with ASCT. The study was able to identify the main features of newly diagnosed ER MM patients eligible for ASCT identifying the IgA isotype and the R2-ISS score system as the main predictive prognostic factors for ER in this cohort of MM patients.
引用
收藏
页码:892 / 895
页数:4
相关论文
共 15 条
[1]   Randomized trial experience of the Intergroupe Francophone du Myelome [J].
Attal, M ;
Harousseau, JL .
SEMINARS IN HEMATOLOGY, 2001, 38 (03) :226-230
[2]   A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma [J].
Attal, M ;
Harousseau, JL ;
Stoppa, AM ;
Sotto, JJ ;
Fuzibet, JG ;
Rossi, JF ;
Casassus, P ;
Maisonneuve, H ;
Facon, T ;
Ifrah, N ;
Payen, C ;
Bataille, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (02) :91-97
[3]   Early relapse after autologous transplant for myeloma is associated with poor survival regardless of cytogenetic risk [J].
Corre, Jill ;
Montes, Lydia ;
Martin, Elodie ;
Perrot, Aurore ;
Caillot, Denis ;
Leleu, Xavier ;
Belhadj, Karim ;
Facon, Thierry ;
Hulin, Cyrille ;
Mohty, Mohamad ;
Fontan, Jean ;
Macro, Margaret ;
Brechignac, Sabine ;
Jaccard, Arnaud ;
Stoppa, Anne-Marie ;
Orsini-Piocelle, Frederique ;
Adiko, Didier ;
Voillat, Laurent ;
Keddar, Faiza ;
Barry, Marly ;
Demarquette, Helene ;
Certain, Marie-Noelle ;
Plantier, Isabelle ;
Roussel, Murielle ;
Hebraud, Benjamin ;
Filleron, Thomas ;
Attal, Michel ;
Avet-Loiseau, Herve .
HAEMATOLOGICA, 2020, 105 (09) :E480-E483
[4]   Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing [J].
D'Agostino, Mattia ;
Zaccaria, Gian Maria ;
Ziccheddu, Bachisio ;
Rustad, Even H. ;
Genuardi, Elisa ;
Capra, Andrea ;
Oliva, Stefania ;
Auclair, Daniel ;
Yesil, Jennifer ;
Colucci, Paola ;
Keats, Jonathan J. ;
Gambella, Manuela ;
Bringhen, Sara ;
Larocca, Alessandra ;
Boccadoro, Mario ;
Bolli, Niccolo ;
Maura, Francesco ;
Gay, Francesca .
CLINICAL CANCER RESEARCH, 2020, 26 (18) :4832-4841
[5]   Revised International Staging System Is Predictive and Prognostic for Early Relapse (<24 months) after Autologous Transplantation for Newly Diagnosed Multiple Myeloma [J].
Gopalakrishnan, Sathish ;
D'Souza, Anita ;
Scott, Emma ;
Fraser, Raphael ;
Davila, Omar ;
Shah, Nina ;
Gale, Robert Peter ;
Kamble, Rammurti ;
Angel Diaz, Miguel ;
Lazarus, Hillard M. ;
Savani, Bipin N. ;
Hildebrandt, Gerhard C. ;
Solh, Melhem ;
Freytes, Cesar O. ;
Lee, Cindy ;
Kyle, Robert A. ;
Usmani, Saad Z. ;
Ganguly, Siddhartha ;
Assal, Amer ;
Berdeja, Jesus ;
Kanate, Abraham S. ;
Dhakal, Binod ;
Meehan, Kenneth ;
Kindwall-Keller, Tamila ;
Saad, Ayman ;
Locke, Frederick ;
Seo, Sachiko ;
Nishihori, Taiga ;
Gergis, Usama ;
Gasparetto, Cristina ;
Mark, Tomer ;
Nieto, Yago ;
Kumar, Shaji ;
Hari, Parameswaran .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (04) :683-688
[6]  
HAROUSSEAU JL, 1995, STEM CELLS, V13, P132
[7]   Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of novel agents [J].
Jimenez-Zepeda, V. H. ;
Reece, D. E. ;
Trudel, S. ;
Chen, C. ;
Tiedemann, R. ;
Kukreti, V. .
BONE MARROW TRANSPLANTATION, 2015, 50 (02) :204-208
[8]   Early Relapse After Autologous Transplant Is Associated With Very Poor Survival and Identifies an Ultra-High-Risk Group of Patients With Myeloma [J].
Kastritis, Efstathios ;
Roussou, Maria ;
Eleutherakis-Papaiakovou, Evangelos ;
Gavriatopoulou, Maria ;
Migkou, Magdalini ;
Gika, Dimitra ;
Fotiou, Despina ;
Kanellias, Nikolaos ;
Ziogas, Dimitrios C. ;
Ntanasis-Stathopoulos, Ioannis ;
Mparmparousi, Despoina ;
Gatou, Anastasia ;
Katopi, Despina ;
Manios, Efstathios ;
Liontos, Michail ;
Giannouli, Stavroula ;
Tsirigotis, Panagiotis ;
Terpos, Evangelos ;
Dimopoulos, Meletios A. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (07) :445-452
[9]   Impact of early relapse after auto-SCT for multiple myeloma [J].
Kumar, S. ;
Mahmood, S. T. ;
Lacy, M. Q. ;
Dispenzieri, A. ;
Hayman, S. R. ;
Buadi, F. K. ;
Dingli, D. ;
Rajkumar, S. V. ;
Litzow, M. R. ;
Gertz, M. A. .
BONE MARROW TRANSPLANTATION, 2008, 42 (06) :413-420
[10]   Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time [J].
Kumar, S. K. ;
Dispenzieri, A. ;
Fraser, R. ;
Mingwei, F. ;
Akpek, G. ;
Cornell, R. ;
Kharfan-Dabaja, M. ;
Freytes, C. ;
Hashmi, S. ;
Hildebrandt, G. ;
Holmberg, L. ;
Kyle, R. ;
Lazarus, H. ;
Lee, C. ;
Mikhael, J. ;
Nishihori, T. ;
Tay, J. ;
Usmani, S. ;
Vesole, D. ;
Vij, R. ;
Wirk, B. ;
Krishnan, A. ;
Gasparetto, C. ;
Mark, T. ;
Nieto, Y. ;
Hari, P. ;
D'Souza, A. .
LEUKEMIA, 2018, 32 (04) :986-995